Novel aspects of oxidative stress in cardiovascular diseases

Circulation Journal

Volumn 73, Issue 2, 2009, Pages 201-207

  Heistad, Donald D ^a   Wakisaka, Yoshinobu ^a   Miller, Jordan ^a   Chu, Yi ^a   Pena Silva, Ricardo ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

Antioxidant mechanisms; Aortic valve stenosis; Oxidative stress; Stroke

Indexed keywords

ANTIOXIDANT; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; VITAMIN;

AORTA STENOSIS; AORTA VALVE STENOSIS; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; NONHUMAN; OXIDATIVE STRESS; REVIEW; STROKE;

ANIMALS; ANTIOXIDANTS; CARDIOVASCULAR DISEASES; DISEASE MODELS, ANIMAL; GENETIC VARIATION; HUMANS; MICE; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; SUPEROXIDE DISMUTASE;

EID: 59449096216     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-08-1082     Document Type: Review

References (44)

1. Griendling KK, Fitzgerald GA. Oxidative stress and cardiovascular injury: Animal and human studies. Circulation 2003; 108: 2034-2040.
2. Heistad DD. Oxidative stress and vascular disease. Arterioscler Thromb Vasc Biol 2006; 26: 689-695.
3. Chen K, Thomas SR, Keaney JF Jr. Beyond LDL oxidation: ROS in vascular signal transduction. Free Radic Biol Med 2003; 35: 117-132.
4. Dröge W. Free radicals in physiological control of cell function. Physiol Rev 2002; 82: 47 - 95.
5. Arimura K, Egashira K, Nakamura R, Ide T, Tsutsui H, Shimokawa H, et al. Increased inactivation of nitric oxide is involved in coronary endothelial dysfunction in heart failure. Am J Physiol Heart 2001; 280: H68 - H75.
6. Morikawa K, Shimokawa H, Matoba T, Kubtoa H, Akaike T, Talukder MAH, et al. Pivotal role of Cu,Zn-superoxide dismutase in endothelium-dependent hyperpolarization. J Clin Invest 2003; 112: 1871 - 1879.
7. Leopold JA, Loscalzo J. Oxidative enzymopathies and vascular disease. Arterioscler Thromb Vasc Biol 2005; 25: 1332 - 1340.
8. Zhao X, Sun G, Zhang J, Strong R, Dash PK, Kan YW, et al. Transcription factor Nrf2 protects the brain from damage produced by intracerebral hemorrhage. Stroke 2007; 38: 3280-3286.
9. St-Pierre J, Drori S, Uldry M, Silvaggi JM, Rhee J, Jäger S, et al. Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcription coactivators. Cell 2006; 127: 397-408.
10. Faraci FM, Didion SP. Vascular protection: Superoxide dismutase isoforms in the vessel wall. Arterioscler Thromb Vasc Biol 2004; 24: 1367 - 1373.
11. Juul K, Tybjaerg-Hansen A, Marklund S, Heegaard NH, Steffensen R, Sillesen H, et al. Genetically reduced anti-oxidative protection and increased ischemic heart disease risk: The Copenhagen City Heart Study. Circulation 2004; 109: 59-65.
12. Jialal I, Devaraj S. Antioxidants and atherosclerosis: Don't throw out the baby with the bath water (editorial). Circulation 2003; 107: 926-928.
13. Rajamannan NM, Bonow RO, Rahimtoola SH. Calcific aortic stenosis: An update. Nat Clin Pract Cardiovasc Med 2007; 4: 254-262.
14. Otto CM, Kuusisto J, Reichenbach DD, Gown AM, O'Brien KD. Characterization of the early lesion of 'degenerative' valvular aortic stenosis: Histological and immunohistochemical studies. Circulation 1994; 90: 844-853.
15. Lindroos M, Kupari M, Valvanne J, Strandberg T, Heikkila J, Tilvis R. Factors associated with calcific aortic valve degeneration in the elderly. Eur Heart J 1994; 15: 865-870.
16. Weiss RM, Ohashi M, Miller JD, Young SG, Heistad DD. Calcific aortic valve stenosis in old hypercholesterolemic mice. Circulation 2006; 114: 2065-2069.
17. Miller JD, Chu Y, Brooks RM, Richenbacher WE, Peña-Silva R, Heistad DD. Dysregulation of antioxidant mechanisms contributes to increased oxidative stress in calcific aortic valvular stenosis in humans. J Am Coll Cardiol 2008; 52: 843 - 850.
18. Liberman M, Bassi E, Martinatti MK, Lario FC, Wosniak J Jr, Pomerantzeff PM, et al. Oxidant generation predominates around calcifying foci and enhances progression of aortic valve calcification. Arterioscler Thromb Vasc Biol 2008; 28: 463 - 470.
19. Vasquez-Vivar J, Kalyanaraman B, Martasek P, Hogg N, Masters BS, Karoui H, et al. Superoxide generation by endothelial nitric oxide synthase: The influence of cofactors. Proc Natl Acad Sci USA 1998; 95: 9220 - 9225.
20. Milstien S, Katusic Z. Oxidation of tetrahydrobiopterin by peroxynitrite: Implications for vascular endothelial function. Biochem Biophys Res Commun 1999; 263: 681-684.
21. Kobayashi S, Inoue N, Azumi H, Seno T, Hirata K, Kawashima S, et al. Expressional changes of the vascular antioxidant system in atherosclerotic coronary arteries. J Atheroscler Thromb 2002; 9: 184 - 190.
22. Towler DA. Oxidation, inflammation, and aortic valve calcification: Peroxide paves an osteogenic path. J Am Coll Cardiol 2008; 52: 851 - 854.
23. Mody N, Parhami F, Sarafian TA, Demer LL. Oxidative stress modulates osteoblastic differentiation of vascular and bone cells. Free Radic Biol Med 2001; 31: 509-519.
24. Shao JS, Aly ZA, Lai CF, Cheng SL, Cai J, Huang E, et al. Vascular Bmp Msx2 Wnt signaling and oxidative stress in arterial calcification. Ann NY Acad Sci 2007; 1117: 40-50.
25. Rajagopalan S, Meng XP, Ramasamy S, Harrison DG, Galis ZS. Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro: Implications for atherosclerotic plaque stability. J Clin Invest 1996; 98: 2572 - 2579.
26. Cowell SJ, Newby DE, Prescott RJ, Bloomfield P, Reid J, Northridge DB, et al. A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis. N Engl J Med 2005; 352: 2389-2397.
27. Rossebø AB, Pedersen TR, Boman K, Brudi P, Chambers JB, Egstrup K, et al. Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis. N Engl J Med 2008; 359: 1343 - 1356.
28. Miller JD, Berry CJ, Serrano KM, Weiss RM, Iyengar NK, Zimmerman KA, et al. Effects of normalizing hyperlipidemia on oxidative stress and disease progression in a mouse model of aortic valve stenosis (abstract). Circulation 2007; 116: II-52.
29. Pena-Silva RA, Miller JD, Heistad DD. Serotonin produces MAO dependent oxidative stress in human heart valves (abstract). FASEB J 2008; 22: 747.6.
30. Iida S, Baumbach GL, Lavoie JL, Faraci FM, Sigmund CD, Heistad DD. Spontaneous stroke in a genetic model of hypertension in mice. Stroke 2005; 36: 1253-1258.
31. Wakisaka Y, Miller JD, Chu Y, Baumbach GL, Wilson S, Faraci FM, et al. Oxidative stress through activation of NAD(P)H oxidase in hypertensive mice with spontaneous intracranial hemorrhage. J Cereb Blood Flow Metab 2008; 28: 1175-1185.
32. Yu F, Kamada H, Niizuma K, Endo H, Chan PH. Induction of MMP-9 expression and endothelial injury by oxidative stress after spinal cord injury. J Neurotrauma 2008; 25: 184-195.
33. Zimmerman MC, Lazartigues E, Sharma RV, Davisson RL. Hypertension caused by angiotensin II infusion involves increased super-oxide production in the central nervous system. Circ Res 2004; 95: 210 - 215.
34. Tang J, Liu J, Zhou C, Ostanin D, Grisham MB, Granger ND, et al. Role of NADPH oxidase in the brain injury of intracerebral hemorrhage. J Neurochem 2005; 94: 1342-1350.
35. Marklund SL. Extracellular superoxide dismutase and other superoxide dismutase isoenzymes in tissues from nine mammalian species. Biochem J 1984; 222: 649-655.
36. Oury TD, Day BJ, Crapo JD. Extracellular superoxide dismutase: A regulator of nitric oxide bioavailability. Lab Invest 1996; 75: 617-636.
37. Chu Y, Iida S, Lund DD, Weiss RM, DiBona GF, Watanabe Y, et al. Gene transfer of extracellular superoxide dismutase reduces arterial pressure in spontaneously hypertensive rats: Role of heparin binding domain. Circ Res 2003; 92: 461-468.
38. Iida S, Chu Y, Weiss RM, Kang YM, Faraci FM, Heistad DD. Vascular effects of a common gene variant of extracellular superoxide dismutase in heart failure. Am J Physiol Heart 2006; 291: H914-H920.
39. Chu Y, Piper R, Richardson S, Watanabe Y, Patel P, Heistad DD. Endocytosis of extracellular superoxide dismutase into endothelial cells: Role of the heparin-binding domain. Arterioscler Thromb Vasc Biol 2006; 26: 1985-1990.
40. Folz RJ, Peno-Green L, Crapo JD. Identification of a homozygous missense mutation (Arg to Gly) in the critical binding region of human EC-SOD gene (SOD3) and its association with dramatically increased serum enzyme levels. Hum Mol Genet 1994; 3: 2251-2254.
41. Chu Y, Alwahdani A, Iida S, Lund DD, Faraci FM, Heistad DD. Vascular effects of human extracellular SODR213G variant. Circulation 2005; 112: 1047-1053.
42. Lund DD, Chu Y, Brooks RM, Faraci FM, Heistad DD. Effects of a common human gene variant of ECSOD on endothelial function after endotoxin in mice. J Physiol (London) 2007; 584.2: 583-590.
43. Yamada H, Yamada Y, Adachi T, Fukatsu A, Sakuma M, Futenma A, et al. Protective role of extracellular superoxide dismutase in hemodialysis patients. Nephron 2000; 84: 218-223.
44. Dahl M, Bowler RP, Juul K, Crapo JD, Levy S, Nordestgaard BG. Superoxide dismutase 3 polymorphism associated with reduced lung function in two large populations. Am J Respir Crit Care Med 2008; 178: 906-912.